
Sponsored Content by AstraZeneca
Advertisement
Articles by Sponsored Content by AstraZeneca



Angeles Alvarez Secord, MD, MHSc, discusses the importance of genetic testing and tumor testing in ovarian cancer and the potential impact on treatment decisions.

Advancing cancer care requires more than just science. It’s a collective effort driven by passionate individuals and organizations dedicated to making a difference for those living with and affected by cancer.

While there are efforts underway to address the significant unmet need for treatments at every stage of the lung cancer continuum, there has been rapid progress in NSCLC.

Immuno-oncology is among the most discussed topics in cancer research, but many are unaware of the science behind this class of treatments. Learn how it works.
Advertisement
Latest Updated Articles
Sponsored Content: The Changing Paradigm of Cancer ResearchNovember 14th 2016
YOUR Cancer Movement Spotlights Oncology HCPs and CommunityJanuary 13th 2019
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
2
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
3
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
4
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
5

